Knowledge at the heart of leadership
Life Sciences Executive Search and Leadership Advisory > Diversity > Liftstream Diversity Events > The Board Meeting on Biopharma Boardroom Diversity 2017 London

The Board Meeting on Biopharma Boardroom Diversity 2017 London

This Liftstream event, in partnership with MedCity, brought together 200 life sciences and investment executives to discuss intentional solutions for increasing boardroom and leadership diversity within the industry. The event explored the business case of diverse leadership, including improved innovation, strategic competitive advantage, financial performance, enhanced company culture and human capital management.
Leaders implementing the UK’s prominent diversity initiatives aimed at increasing the participation of women and under-represented groups in UK business also shared their experience, insights and best-practice to enact change.
The event format built on the very successful annual diversity conference Liftstream hosts in the United States.

Event Location: BMA, Tavistock Square, London. WC1H 9JP. - United Kingdom

Event Date: March 28th 2017 

Event Schedule:

3.00pm - 3.30pm – Event Registration and Networking

3.30pm – 3.40pm – Welcoming Address

3.40pm – 4.00pm – “Why Diversity” Presentation

4.00pm – 4.30pm – Panel – Surveying the UK’s Diversity Landscape: Policies and Programmes...Action to Embed Lasting Change!
4.30pm – 4.45pm – Expert Presentation to the Board 

4.45pm – 5.00pm – Coffee Break

5.00pm – 6.30pm – ‘The Board Meeting’ (main panel)

Under the direction of a Chairperson, a gender balanced board of leading industry executives debated the value of diverse leadership. The board's agenda tackled the most prominent questions in the three following areas:

• Leadership
• Investing, Venture, and Management 
• Boardroom Process and Governance

6.30pm – 7.30pm – Networking Reception and Close

Speakers included:

Dr Annalisa Jenkins - CEO of Dimension Therapeutics and non-executive director of MedCity, Ardelyx, Biothera, and Viventia Bio, Inc.; John Berriman - Chairman at Confo Therapeutics, Depixus, ReNeuron Group, Autifony Therapeutics; Dr Denise Scots-Knight - CEO and Founder at Mereo Biopharma Group, Plc., non-executive director OncoMed and Albireo; Prof. Isabel Fernandez-Mateo - Professor of Strategy and Entrepreneurship, London Business School, Jeanne Bolger - VP Venture Investments, J&J Innovation JJDC Denis Woulfe - Partner and Vice Chairman, Deloitte, Co-Chair MACA and Board Member of Women's Business Council; Gerry Brown, Chairman, Novaquest Capital Management,  Pavita Cooper, Steering Committee Member of 30% Club, Chair of CMI Diversity Advisory Group and Founder of More Difference. Roel Bulthuis, SVP and Managing Director, Merck Ventures, Dr Elena Doldor, Assistant Professor in Organizational Behaviour, School of Business and Management Queen Mary University of London and Senior Research Fellow - Cranfield School of Management, Catherine Moukheibir, Chairperson of MedDay Pharma, non-executive director Ablynx, Cerenis and Zealand Pharma; Dr Yvonne Thompson CBE, Entrepreneur, Author and Steering Committee Member of the Parker Review. Dr Stephen Bunting, Chairman, Abingworth LLP., Paul George, Executive Director of Corporate Governance and Reporting, Financial Reporting Council


comments powered by Disqus
If you are interested in job opportunities please register here

Featured content


Contact Us

   Head Office
Liftstream Ltd.
111 Buckingham Palace Road,
   Tel: ​+44 (0)20 3180 5880

Register your CV

Apply for executive or board positions by submitting your CV

Registered in England No: 5009233
VAT: 843679292

Follow Us